LANXESS worldwide

Corporate Website en | de


  • Australia en

  • China cn | en

  • India en

  • Indonesia en

  • Japan jp

  • Korea kr

  • Malaysia en

  • Pakistan en

  • Philippines en

  • Singapore en

  • Thailand en

  • Vietnam en


  • Austria en

  • Belgium nl

  • Czech en

  • France fr

  • Hungary en

  • Italy en

  • Netherlands en

  • Poland en

  • Russia en

  • Serbia en

  • Slovakia en

  • Spain en

  • Turkey en

  • United Arab Emirates en

  • United Kingdom en




Strict hygiene protocols essential in the fight against African Swine Fever global spread, MPP, Virkon

Pittsburgh, Pa. – June 5, 2019– With African Swine Fever (ASF) continuing its rapid and devastating spread across Europe, China and Southeast Asia, and with no vaccine or other medical treatment currently available, hog producers are being warned about the increased risk of ASF possibly reaching the United States.


Virkon S proven effective against African Swine Fever virus1*


Specialty chemicals company LANXESS is offering U.S. swine producers the proven broad spectrum disinfectant and virucide Virkon S, which is effective at killing the African Swine Fever virus. Having been independently tested for virucidal efficacy against ASF1*, Virkon S is proven to be effective against the disease at a dilution rate of 1:100 in the presence of organic challenge.  


“The independent test result provides proven data on the ability of Virkon S to kill ASF,” explains Ryan T. Domack, sales manager of Market Segment Disinfection in the Material Protection Products (MPP) business unit at LANXESS. 


“Implementing strict disinfection barrier controls is the only real way of stopping the spread of swine diseases from one production site to another,” Domack continues. “Therefore, producers need to achieve the highest possible levels of hygiene, utilizing an independently proven effective disinfectant, which is effective against diseases that have catastrophic effects on farm productivity and mortality rates.”


In addition, LANXESS provides customized technical support to swine producers to help protect against pathogens such as ASF1* in applications across the range of possible infection vectors, including other animals, transport vehicles, housing facilities and personnel.


“Virkon S is scientifically formulated to address the major disease concerns facing modern livestock production. Its formulation, based on extensive scientific research, offers swine producers a disinfectant that has helped define livestock production hygiene standards for over 30 years, making it the disinfectant of choice against ASF,” adds Domack.


Further information can be found at



For complete directions for use and the full list of approved pathogens, please consult the product label.



1 African Swine Fever Virus efficacy was tested with 1% soil load and 342 ppm hard water.

* Not approved in California for use against the noted pathogens.



LANXESS is a leading specialty chemicals company with sales of EUR 7.2 billion in 2018. The company currently has about 15,500 employees in 33 countries and is represented at 60 production sites worldwide. The core business of LANXESS is the development, manufacturing and marketing of chemical intermediates, additives, specialty chemicals and plastics. LANXESS is listed in the leading sustainability indices Dow Jones Sustainability Index (DJSI World and Europe) and FTSE4Good.


Forward-Looking Statements
This company release contains certain forward-looking statements, including assumptions, opinions, expectations and views of the company or cited from third party sources. Various known and unknown risks, uncertainties and other factors could cause the actual results, financial position, development or performance of LANXESS AG to differ materially from the estimations expressed or implied herein. LANXESS AG does not guarantee that the assumptions underlying such forward-looking statements are free from errors nor does it accept any responsibility for the future accuracy of the opinions expressed in this presentation or the actual occurrence of the forecast developments. No representation or warranty (expressed or implied) is made as to, and no reliance should be placed on, any information, estimates, targets and opinions, contained herein, and no liability whatsoever is accepted as to any errors, omissions or misstatements contained herein, and accordingly, no representative of LANXESS AG or any of its affiliated companies or any of such person's officers, directors or employees accept any liability whatsoever arising directly or indirectly from the use of this document.




Information for editors:

You can find further information concerning LANXESS chemistry in our WebMagazine at


Follow us on Twitter, Facebook, Linkedin and YouTube:


Leanne Trevelline
Corporate Communications

Phone: +1 412-809-1515

send E-Mail